Comparative study of triple intravenous chemotherapy versus dual chemotherapy combined with hepatic arterial infusion in patients with liver metastases from colorectal cancer

Aimin Zhou, Lichao Wang, Chijin Xiao, Yunan Shi · 2026

Read Comparative study of triple intravenous chemotherapy versus dual chemotherapy combined with hepatic arterial infusion in patients with liver metastases from colorectal cancer by Aimin Zhou, Lichao Wang, Chijin Xiao, Yunan Shi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13322887.txt.

Description

Aimin Zhou and colleagues compare two chemotherapy routes for colorectal cancer spread to the liver, in a 2026 single-centre study. Records cover 132 patients with liver spread that could not be removed, treated between 2019 and 2023 at a hospital linked to Yichun University.

One group received the triple drug plan FOLFOXIRI, and the other received FOLFIRI plus chemotherapy infused through the hepatic artery. The second group held disease back longer, with median time without growth of 10.3 months against 8.2 months for the triple plan, and had higher rates of tumour shrinkage and disease control. Overall survival looked slightly longer too, though that gap was not firm. Side effects were compared across both groups.

Catalog record

CREATORAimin Zhou, Lichao Wang, Chijin Xiao, Yunan Shi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38971
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13322887

Browse the full library · About the Tower of Babel